CU20130003A7 - Procedimiento de preparacion de la sal de l-arginina de perindoprilo. - Google Patents

Procedimiento de preparacion de la sal de l-arginina de perindoprilo.

Info

Publication number: CU20130003A7
Authority: CU; Cuba
Prior art keywords: perindopril; preparation procedure; arginine salt; arginine; salt
Prior art date: 2012-01-05

Application number

CU20130003A

Other languages

English (en)

Other versions

CU24293B1 (es

Inventor

Linol Julie

Laurent Stephane

Grenier Arnaud

Mathieu Sebastien

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-01-05

Filing date

2013-01-04

Publication date

2014-08-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47427278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU20130003(A7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-01-04 Application filed by Servier Lab filed Critical Servier Lab

2014-08-28 Publication of CU20130003A7 publication Critical patent/CU20130003A7/es

2017-12-08 Publication of CU24293B1 publication Critical patent/CU24293B1/es

Links

ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical class OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 title 1
IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title 1
229960002582 perindopril Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CUP2013000003A 2012-01-05 2013-01-04 Procedimiento de preparación de la sal de l-arginina de perindoprilo CU24293B1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR1200034A FR2985512B1 (fr)	2012-01-05	2012-01-05	Procede de preparation du sel de l-arginine du perindopril

Publications (2)

Publication Number	Publication Date
CU20130003A7 true CU20130003A7 (es)	2014-08-28
CU24293B1 CU24293B1 (es)	2017-12-08

Family

ID=47427278

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CUP2013000003A CU24293B1 (es)	2012-01-05	2013-01-04	Procedimiento de preparación de la sal de l-arginina de perindoprilo

Country Status (46)

Country	Link
US (1)	US8865915B2 (es)
EP (1)	EP2612851B1 (es)
JP (1)	JP5722924B2 (es)
KR (1)	KR101502946B1 (es)
CN (1)	CN103193863B (es)
AP (1)	AP2013006655A0 (es)
AR (1)	AR089632A1 (es)
AU (1)	AU2012268816B2 (es)
BR (1)	BR102013000256B1 (es)
CA (1)	CA2801089C (es)
CL (1)	CL2013000022A1 (es)
CO (1)	CO6700138A1 (es)
CR (1)	CR20120654A (es)
CU (1)	CU24293B1 (es)
CY (1)	CY1118079T1 (es)
DK (1)	DK2612851T3 (es)
EA (1)	EA022573B1 (es)
EC (1)	ECSP13012366A (es)
ES (1)	ES2595236T3 (es)
FR (1)	FR2985512B1 (es)
GE (1)	GEP20146183B (es)
GT (1)	GT201300002A (es)
HR (1)	HRP20161145T1 (es)
HU (1)	HUE030042T2 (es)
IL (1)	IL223753A (es)
JO (1)	JO3196B1 (es)
LT (1)	LT2612851T (es)
MA (1)	MA35001B1 (es)
MD (1)	MD4415C1 (es)
ME (1)	ME02493B (es)
MX (1)	MX2013000009A (es)
MY (1)	MY160902A (es)
NI (1)	NI201200195A (es)
PE (1)	PE20131098A1 (es)
PH (1)	PH12012000392A1 (es)
PL (1)	PL2612851T3 (es)
PT (1)	PT2612851T (es)
RS (1)	RS55096B1 (es)
SA (1)	SA113340172B1 (es)
SG (1)	SG192337A1 (es)
SI (1)	SI2612851T1 (es)
TN (1)	TN2012000620A1 (es)
TW (1)	TWI449693B (es)
UA (1)	UA111333C2 (es)
UY (1)	UY34553A (es)
WO (1)	WO2013102740A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2016178591A2 (en)	2015-05-05	2016-11-10	Gene Predit, Sa	Genetic markers and treatment of male obesity
TWI544987B (zh)	2015-10-27	2016-08-11	財團法人工業技術研究院	輕便型動力工具
EP3692520A4 (en)	2017-10-06	2021-07-28	Rad, Steve	AUGMENTED REALITY SYSTEM AND KIT
US10430658B2 (en)	2017-10-06	2019-10-01	Steve Rad	Augmented reality system and kit
CN110283104B (zh) *	2018-08-22	2022-06-14	南京济群医药科技股份有限公司	一种精氨酸培哚普利的制备方法
CN112047999B (zh) *	2020-09-18	2022-12-02	天津力生制药股份有限公司	一种γ晶型的精氨酸培哚普利盐的制备方法
CN114149357B (zh) *	2021-12-29	2024-06-25	江苏嘉逸医药有限公司	一种γ晶型培哚普利精氨酸盐的制备方法
CN114894940B (zh) *	2022-06-02	2024-09-06	江苏嘉逸医药有限公司	一种高效液相色谱法测定精氨酸培哚普利中杂质的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2503155A2 (fr) *	1980-10-02	1982-10-08	Science Union & Cie	Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2620709B1 (fr) *	1987-09-17	1990-09-07	Adir	Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
AR036187A1 (es) *	2001-07-24	2004-08-18	Adir	Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
FR2838648B1 (fr) *	2002-04-18	2004-05-21	Servier Lab	Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
CN100472337C (zh)	2003-09-18	2009-03-25	澳大利亚研究实验室持股有限公司	提高液体静电印刷调色剂或液体喷墨油墨的物理性质和电性质的方法
US7291745B2 (en) *	2005-03-21	2007-11-06	Glenmark Pharmaceuticals Limited	Process for the preparation of perindopril
FR2897865B1 (fr) *	2006-02-28	2008-04-18	Servier Lab	Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897866B1 (fr) *	2006-02-28	2008-04-18	Servier Lab	Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EP1864973A1 (en) *	2006-06-09	2007-12-12	Sochinaz SA	Process for the preparation of perindopril and salts thereof
DK2318365T3 (en) *	2008-06-24	2015-11-23	Mylan Lab Ltd	NOVEL polymorphic forms of perindopril (L) -arginine AND PROCESS FOR PREPARATION THEREOF
AU2009212902A1 (en)	2008-09-03	2010-03-18	Apotex Pharmachem Inc.	Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
SI23001A (sl) *	2009-03-20	2010-09-30	Diagen@d@o@o	Nove soli perindoprila nov postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni

2012
- 2012-01-05 FR FR1200034A patent/FR2985512B1/fr not_active Expired - Fee Related
- 2012-12-18 PH PH12012000392A patent/PH12012000392A1/en unknown
- 2012-12-19 JO JOP/2012/0384A patent/JO3196B1/ar active
- 2012-12-19 SG SG2012093589A patent/SG192337A1/en unknown
- 2012-12-19 CR CR20120654A patent/CR20120654A/es unknown
- 2012-12-20 AU AU2012268816A patent/AU2012268816B2/en active Active
- 2012-12-20 PE PE2012002463A patent/PE20131098A1/es not_active Application Discontinuation
- 2012-12-20 IL IL223753A patent/IL223753A/en active IP Right Grant
- 2012-12-25 TN TNP2012000620A patent/TN2012000620A1/fr unknown
- 2012-12-26 CO CO12232909A patent/CO6700138A1/es unknown
- 2012-12-27 UY UY0001034553A patent/UY34553A/es unknown
- 2012-12-27 MY MYPI2012701295A patent/MY160902A/en unknown
- 2012-12-27 TW TW101150662A patent/TWI449693B/zh active
- 2012-12-27 NI NI201200195A patent/NI201200195A/es unknown
- 2012-12-28 EA EA201201667A patent/EA022573B1/ru unknown
- 2012-12-28 MD MDA20120129A patent/MD4415C1/ro active IP Right Grant
2013
- 2013-01-02 MA MA35525A patent/MA35001B1/fr unknown
- 2013-01-02 SA SA113340172A patent/SA113340172B1/ar unknown
- 2013-01-02 AP AP2013006655A patent/AP2013006655A0/xx unknown
- 2013-01-03 UA UAA201300118A patent/UA111333C2/uk unknown
- 2013-01-03 AR ARP130100016A patent/AR089632A1/es not_active Application Discontinuation
- 2013-01-03 CL CL2013000022A patent/CL2013000022A1/es unknown
- 2013-01-03 CA CA 2801089 patent/CA2801089C/fr active Active
- 2013-01-03 US US13/733,353 patent/US8865915B2/en active Active
- 2013-01-04 HU HUE13150305A patent/HUE030042T2/en unknown
- 2013-01-04 JP JP2013000108A patent/JP5722924B2/ja active Active
- 2013-01-04 ES ES13150305.4T patent/ES2595236T3/es active Active
- 2013-01-04 WO PCT/FR2013/050017 patent/WO2013102740A1/fr not_active Ceased
- 2013-01-04 KR KR1020130001012A patent/KR101502946B1/ko active Active
- 2013-01-04 SI SI201330308A patent/SI2612851T1/sl unknown
- 2013-01-04 CN CN201310001282.2A patent/CN103193863B/zh active Active
- 2013-01-04 PL PL13150305.4T patent/PL2612851T3/pl unknown
- 2013-01-04 CU CUP2013000003A patent/CU24293B1/es unknown
- 2013-01-04 EP EP13150305.4A patent/EP2612851B1/fr active Active
- 2013-01-04 LT LTEP13150305.4T patent/LT2612851T/lt unknown
- 2013-01-04 ME MEP-2016-171A patent/ME02493B/me unknown
- 2013-01-04 EC ECSP13012366 patent/ECSP13012366A/es unknown
- 2013-01-04 RS RS20160720A patent/RS55096B1/sr unknown
- 2013-01-04 GE GEAP201312951A patent/GEP20146183B/en unknown
- 2013-01-04 DK DK13150305.4T patent/DK2612851T3/en active
- 2013-01-04 BR BR102013000256-9A patent/BR102013000256B1/pt active IP Right Grant
- 2013-01-04 GT GT201300002A patent/GT201300002A/es unknown
- 2013-01-04 PT PT131503054T patent/PT2612851T/pt unknown
- 2013-01-07 MX MX2013000009A patent/MX2013000009A/es active IP Right Grant
2016
- 2016-09-06 HR HRP20161145TT patent/HRP20161145T1/hr unknown
- 2016-10-05 CY CY20161100993T patent/CY1118079T1/el unknown

Also Published As

Publication number	Publication date
EA201201667A1 (ru)	2013-09-30
NI201200195A (es)	2013-06-03
CO6700138A1 (es)	2013-06-28
ES2595236T3 (es)	2016-12-28
IL223753A0 (en)	2013-07-31
PT2612851T (pt)	2016-08-01
HRP20161145T1 (hr)	2016-11-18
MD4415C1 (ro)	2016-11-30
US20130178635A1 (en)	2013-07-11
CN103193863A (zh)	2013-07-10
UA111333C2 (uk)	2016-04-25
EP2612851A1 (fr)	2013-07-10
SA113340172B1 (ar)	2015-07-09
MA35001B1 (fr)	2014-04-03
PL2612851T3 (pl)	2016-12-30
RS55096B1 (sr)	2016-12-30
TWI449693B (zh)	2014-08-21
ECSP13012366A (es)	2014-08-29
TN2012000620A1 (fr)	2014-04-01
AU2012268816B2 (en)	2014-12-11
ME02493B (me)	2017-02-20
CA2801089C (fr)	2015-03-31
TW201332969A (zh)	2013-08-16
DK2612851T3 (en)	2016-10-03
FR2985512B1 (fr)	2014-06-20
MY160902A (en)	2017-03-31
GT201300002A (es)	2014-06-09
US8865915B2 (en)	2014-10-21
CY1118079T1 (el)	2017-06-28
UY34553A (es)	2013-07-31
JP5722924B2 (ja)	2015-05-27
AP2013006655A0 (en)	2013-01-31
BR102013000256B1 (pt)	2020-06-02
FR2985512A1 (fr)	2013-07-12
CN103193863B (zh)	2017-03-01
BR102013000256A2 (pt)	2013-12-03
MD20120129A2 (en)	2013-07-31
SI2612851T1 (sl)	2016-11-30
WO2013102740A1 (fr)	2013-07-11
MX2013000009A (es)	2013-07-15
AU2012268816A1 (en)	2013-07-18
PH12012000392B1 (en)	2014-07-28
JP2013139445A (ja)	2013-07-18
CL2013000022A1 (es)	2014-07-25
GEP20146183B (en)	2014-10-27
AR089632A1 (es)	2014-09-03
CU24293B1 (es)	2017-12-08
PE20131098A1 (es)	2013-10-12
CR20120654A (es)	2013-09-03
SG192337A1 (en)	2013-08-30
KR20130080813A (ko)	2013-07-15
HUE030042T2 (en)	2017-04-28
JO3196B1 (ar)	2018-03-08
EP2612851B1 (fr)	2016-07-06
IL223753A (en)	2015-08-31
KR101502946B1 (ko)	2015-03-16
PH12012000392A1 (en)	2014-07-28
MD4415B1 (ro)	2016-04-30
EA022573B1 (ru)	2016-01-29
LT2612851T (lt)	2016-09-26
CA2801089A1 (fr)	2013-07-05

Publication	Publication Date	Title
LTC2785706I2 (lt)	2023-07-10	Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
BR112014017749A2 (pt)	2017-06-20	Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo
HUE037048T2 (hu)	2018-08-28	Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására
CO6970589A2 (es)	2014-06-13	Ansolvatos de sal de noribogaina
LT3321276T (lt)	2021-11-10	Sulieti baltymai, skirti metabolinių sutrikimų gydymui
EP2928483A4 (en)	2016-06-08	Immunotherapy with binding agents
CO7061071A2 (es)	2014-09-19	Procesos para la preparación de (s)-1-(3-etoxi-4-metoxifenil)-2-metansulfoniletilamina
EP2838450A4 (en)	2015-09-02	STEERING ENDOLUMINAL STANZER
EP2680775A4 (en)	2014-10-01	Cryogenic medical system
EP2863918A4 (en)	2016-01-13	SALT CRYSTALS
BR112014028334A2 (pt)	2018-05-29	derivados dipeptídicos de lisina ácido glutâmico.
UA24447S (uk)	2013-03-11	М'ясорубка
CU20130003A7 (es)	2014-08-28	Procedimiento de preparacion de la sal de l-arginina de perindoprilo.
EP2742886A4 (en)	2015-04-08	SURGICAL SYSTEM
EP2759249A4 (en)	2015-09-02	Endoscope system
PT2931313T (pt)	2019-07-10	Formulações de solução de anticorpos anti-il-23p19 modificados
EP2801264A4 (en)	2015-09-09	Salty taste enhancer
SMT201600440B (it)	2017-01-10	Capsula per la preparazione di bevande
CO7020857A2 (es)	2014-08-11	Procedimiento para la preparación de complejos de 68ga
CY2022038I1 (el)	2023-01-27	Λυοφιλοποιημενη παρασκευη κυτταροτοξικων διπεπτιδιων
LT2872145T (lt)	2022-06-27	Sujungti benzazepinai tureto sindromui gydyti
ES2397885B1 (es)	2014-02-05	Derivados de colismicina.
FR2997638B1 (fr)	2015-01-02	Cristallisoir
ES1075788Y (es)	2012-03-01	Bandeja de cultivo-presentacion de productos horticolas.
ES1076501Y (es)	2012-06-12	Mufla para la elaboración de prótesis dentales.